Sort
39,280 grants matching “leukemia”
Peptide-directed protocells and virus-like particles-new nanoparticle platforms f
$353,085Cheryl L Willman · University Of New Mexico Health Scis Ctr · U01 · FY2012 · CA
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
$353,076Lee Ratner · Washington University · R01 · FY2023 · CA
Signal Transduction Therapy--Clinical
$353,072Elise C. Kohn · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Characterization of SLE-susceptibility loci on mouse chromosome 1
$353,053Laurence Morel · University Of Florida · R01 · FY2014 · AI
Ionizing radiation induced hematological malignancies
$353,050Daohong Zhou · University Of Florida · R01 · FY2020 · CA
IMMUNE MONITORING CORE
$353,045Trudy Nan Small · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Erythroid Development in the Mammalian Embryo
$353,019Margaret H. Baron · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · DK
Molecular Genetics of Segment Identity
$353,008Richard S Mann · Columbia University Health Sciences · R01 · FY2009 · GM
Targeting cell trafficking as a new therapeutic modality for Multiple Myeloma
$352,995Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis
$352,969Dorothy A Sipkins · Duke University · R01 · FY2022 · CA
Polysomy 21 in Acute Lymphoblastic Leukemia
$352,946David Marc Weinstock · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Polysomy 21 in Acute Lymphoblastic Leukemia
$352,946David Marc Weinstock · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Polysomy 21 in Acute Lymphoblastic Leukemia
$352,946David Marc Weinstock · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Polysomy 21 in Acute Lymphoblastic Leukemia
$352,946David Marc Weinstock · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Repressor/co-repressor oligomerization and development
$352,934Albert J Courey · University Of California Los Angeles · R01 · FY2011 · GM
Studies of other risk factors for radiosensitive tumors
$352,895Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Occupational and Environmental Determinants of Cancer among Women and Minorities
$352,884Laura Beane Freeman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Regulation of the Mono-Ubiquitination of the Fanconi Anemia D2 Protein
$352,868Niall George Howlett · University Of Rhode Island · R01 · FY2014 · HL
Targeting aberrant epigenetics by nanomedicine
$352,817Shujun Liu · Ohio State University · R01 · FY2011 · CA
Mechanism of non-oncogene addiction
$352,801Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · CA
Targeting Chk1 in Acute Myeloid Leukemia
$352,801Larry M Karnitz · Mayo Clinic Rochester · R01 · FY2019 · CA
Metabolic reprogramming in breast cancer
$352,801Zhaohui Feng · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA
FA pathway activities in the normal and transformed epidermis
$352,801Susanne Irmtraud Wells · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · CA
Develop CTC capture technology for both mesenchymal and non-mesenchymal tumors
$352,800Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · EB
Novel Strategies for Treatment of Myeloproliferative Disorders
$352,750Roya Khosravi-Far · Beth Israel Deaconess Medical Center · R01 · FY2009 · CA